Surufatinib or Surufatinib Combined With Vinorelbine for Non-Small Cell Lung Cancer
Surufatinib or Surufatinib Combined With Vinorelbine for Non-Small Cell Lung Cancer
Active, not recruiting · NCT04922658 · Registry updated 2026-07-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Surufatinib or Surufatinib Combined With Vinorelbine for Non-Small Cell Lung Cancer | Advanced Non-Small Cell Lung Cancer | Active, not recruiting | Phase 2 | 2026-07-15 | NCT04922658 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Affiliated Cancer Hospital & Institute of Guangzhou Medical University | 33 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Affiliated Cancer Hospital and institute of Guangzhou Medical University | Guangzhou | China | 5 |